hnRNPA2/B1 is a novel COX-2 regulator which can specifically bind to COX-2 promoter in NSCLC cells.
hnRNPA2/B1 activates COX-2 expression, upregulates PGE2 production, and promotes cell growth in NSCLC cells.
hnRNPA2/B1 expression is positively correlated with COX-2 expression in NSCLC and predicts poor prognosis in lung cancer patients.
P300 interacts with and acetylates hnRNPA2/B1 protein, thereby promoting COX-2 expression and cell growth in NSCLC cells.